Literature DB >> 22751444

Updated results from the European Randomized Study of Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: are Asian countries encouraged to promote PSA screening?

Mikio Sugimoto1, Yoshiyuki Kakehi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22751444      PMCID： PMC3720072          DOI： 10.1038/aja.2012.50

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  21 in total

1.  Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association.

Authors: 
Journal:  Int J Urol       Date:  2005-01       Impact factor: 3.369

2.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Authors:  Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Varambally; Xuhong Cao; Joelle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

3.  APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer.

Authors:  Jack Groskopf; Sheila M J Aubin; Ina Lim Deras; Amy Blase; Sharon Bodrug; Craig Clark; Steven Brentano; Jeannette Mathis; Jimmykim Pham; Troels Meyer; Michelle Cass; Petrea Hodge; Maria Luz Macairan; Leonard S Marks; Harry Rittenhouse
Journal:  Clin Chem       Date:  2006-04-20       Impact factor: 8.327

4.  Prospective validation of active surveillance in prostate cancer: the PRIAS study.

Authors:  Roderick C N van den Bergh; Stijn Roemeling; Monique J Roobol; Wouter Roobol; Fritz H Schröder; Chris H Bangma
Journal:  Eur Urol       Date:  2007-05-25       Impact factor: 20.096

Review 5.  Active surveillance as a practical strategy to differentiate lethal and non-lethal prostate cancer subtypes.

Authors:  Yoshiyuki Kakehi
Journal:  Asian J Androl       Date:  2012-04-16       Impact factor: 3.285

6.  Morphological features of TMPRSS2-ERG gene fusion prostate cancer.

Authors:  J-M Mosquera; S Perner; F Demichelis; R Kim; M D Hofer; K D Mertz; P L Paris; J Simko; C Collins; T A Bismar; A M Chinnaiyan; M A Rubin
Journal:  J Pathol       Date:  2007-05       Impact factor: 7.996

7.  Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.

Authors:  Arnauld Villers; Philippe Puech; Damien Mouton; Xavier Leroy; Charles Ballereau; Laurent Lemaitre
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

8.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

9.  Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer.

Authors:  Yoshiyuki Kakehi; Toshiyuki Kamoto; Taizou Shiraishi; Osamu Ogawa; Yoshimi Suzukamo; Shunichi Fukuhara; Yuko Saito; Ken-Ichi Tobisu; Tadao Kakizoe; Taro Shibata; Haruhiko Fukuda; Koichiro Akakura; Hiroyoshi Suzuki; Nobuo Shinohara; Shin Egawa; Akira Irie; Takefumi Sato; Osamu Maeda; Norio Meguro; Yoshiteru Sumiyoshi; Takanori Suzuki; Nobuaki Shimizu; Yoichi Arai; Akito Terai; Tetsuro Kato; Tomonori Habuchi; Hiroyuki Fujimoto; Masashi Niwakawa
Journal:  Jpn J Clin Oncol       Date:  2008-02-12       Impact factor: 3.019

10.  Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

Authors:  Brenda E Sirovich; Lisa M Schwartz; Steven Woloshin
Journal:  JAMA       Date:  2003-03-19       Impact factor: 56.272
View more
  1 in total

1.  Reference Ranges of Age-Related Prostate-Specific Antigen in Men without Cancer from Beijing Area.

Authors:  Xin Liu; Jie Wang; Shun-Xin Zhang; Qian Lin
Journal:  Iran J Public Health       Date:  2013-11       Impact factor: 1.429
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.